Epigenomics AG (EPGNF)

Market Cap	843.49K
Revenue (ttm)	97.32K
Net Income (ttm)	-3.47M
Shares Out	n/a
EPS (ttm)	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	8,000
Average Volume	2,068
Open	0.7893
Previous Close	0.5000
Day's Range	0.7893 - 0.7950
52-Week Range	0.5000 - 2.5000
Beta	1.17
RSI	49.73
Earnings Date	May 9, 2025

About Epigenomics AG

Epigenomics AG does not have significant operations. Previously, it was involved in liquid biopsy for the early detection of cancer. The company was founded in 1998 and is based in Heidelberg, Germany.

• Industry: Diagnostics & Research
• Sector: Healthcare
• Founded: 1998
• Employees: 6
• Stock Exchange: OTCMKTS
• Ticker Symbol: EPGNF

Financial Performance

In 2024, Epigenomics AG's revenue was 94,000, a decrease of -72.29% compared to the previous year's 339,227. Losses were -3.35 million, -24.90% less than in 2023.

Financial numbers in EUR